An open-label study of a once daily dose of emtricitabine in combination with other antiretroviral agents in HIV-infected pediatric patients
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Emtricitabine; Lopinavir/ritonavir; Stavudine
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 24 Oct 2005 New trial record.